Oryzon Genomics S.A. ( ORYZF) - Stock Earnings
ORYZF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 29, 2026, midnight | — / — | — | — / — | — |
ORYZF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 395769 USD | — USD |
| 2025Q4 | -1.6 million USD | — USD |
| 2026Q1 | -1.4 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ORYZF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.7 million USD | 15.7 million USD |
| 2024 | -3.8 million USD | 7.7 million USD |
| 2025 | -3.1 million USD | — USD |
| 2026 Est. | — | — |
ORYZF
Price: $3.66
52 week price:
Earnings Per Share: -0.03 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 283.3 million